Tetracycline analogue-regulated transgene expression Plasmodium falciparum blood stages using
Toxoplasma gondii transactivators
Markus Meissnerâ€ â€¡Â§Â¶, Efrosinia Krejanyâ€ Â¶, Paul R. Gilsonâ€ , Tania F. Koning-Wardâ€ , Dominique Soldatiâ€¡å‚¨, Brendan S. Crabbâ€ ,â€ â€ 
 Walter Eliza Hall Institute Medical Research, 1G Royal Parade, Parkville VIC 3050, Australia; â€¡Department Biological Sciences, Imperial College
 Science, Technology, Medicine, Imperial College Road, London SW7 2AZ, United Kingdom; Â§Abteilung Parasitologie, Hygiene-Institut,
UniversitaÂ¨tsklinikum Heidelberg, Im Neuenheimer Feld 324, D-69120 Heidelberg, Germany

Communicated Louis H. Miller, National Institutes Health, Rockville, MD, January 6, 2005 (received review November 16, 2004)

Genetic manipulation revolutionized research Apicom-                  establishing anhydrotetracycline (ATc)-regulated gene ex-
plexan parasite Plasmodium falciparum, important caus-                  pression systems Toxoplasma gondii, distant relative P.
ative agent malaria.  date techniques                 falciparum (5, 6).
established allow modifications deleterious blood-                 effective approaches developed T.
stage growth, disruption essential genes                   gondii based Tet-transactivator  mammalian
expression dominant-negative transgenes. recent establish-                cells, uses fusion protein Tet repressor (TetR)
ment screen functional transactivators related                   C-terminal transactivating domain herpes sim-
parasite Toxoplasma gondii prompted identify transactiva-                  plex virus VP16 protein, process converts repressor
tors T. gondii examine functionality P. falciparum.           efficient Tet-controlled transactivator (tTA) (7). Tetracycline-responsive minimal promoters generated based                   attempts adapt T. gondii failed tTA characterized P. falciparum calmodulin promoter used                  capable activating minimal promoters derived assess transactivators P. falciparum. demonstrate                  organism (5).  genetic screen based random
artificial tetracycline-regulated transactivators isolated T. gondii          insertion designed identify functional transcriptional functional P. falciparum. using tetracycline                  activating domain T. gondii establish ATc transac-
analogue anhydrotetracycline, efficient, stage-specific gene regu-               tivator-based regulation  new permitted lation achieved P. falciparum. regulatable expression                creation conditional knockout essential gene T.
technology clear potential study essential gene                   gondii (6).
function P. falciparum blood stages. hand,                       report reversible expression genes P.
identified transactivators functional mammalian cells,                falciparum, using employs ATc-regulated
consistent fundamental differences mechanism                  transactivators identified T. gondii activate P. falciparum
gene regulation Apicomplexan parasites human                   minimal promoters. observed â¬Ž50-fold regulation hosts.                                                                           GFP reporter gene using ATc course single 48-h
                                                                                 growth cycle, 10- 20-fold regulation achieved
Apicomplexa å…© transcription å…© gene regulation å…© anhydrotetracycline å…©            chloramphenicol acetyltransferase (CAT) reporter inducible expression                                                             growth cycles. broad applicability
                                                                                 analysis important gene functions P. falciparum

P   lasmodium falciparum causative agent     severe form human malaria. years, powerful new tools strategies associated DNA trans-
                                                                                 blood stages.

                                                                                 Materials Methods
formation developed clinically relevant blood                   Plasmids. T. gondii TATi-2 expression plasmid generated
stage organism  reviews, refs. 1 2).                 previously described pTTATi-1-HX (6) using poly(T) number reasons, notably low efficiency                      primer BamHI restriction site 3â¬˜ end Rep-4
transfection (3), genetic manipulations slight                  (5â¬˜-CGGA TCCT T T TCGACA ATGTCGCGCCTG-
deleterious effect erythrocyte-stage growth                    GACAAGAGCAAAGTCATCAACTCTGC-3â¬˜) primers difficult perform. include expression transgenes                 amplification. generation plasmid allowing stable negatively impact growth deletion genes play                expression TATi-3, oligonucleotides encoding transacti- crucial role maintenance blood-stage cycle,                 vating domain generated (TATi-3-sense, 5â¬˜-TTATCTC-
especially problematic given haploid nature genome                    CTGCCAACGTGCATCCCTTAAT-3â¬˜, TATi-3  5â¬˜- stage. technical deficiency major roadblock functional analysis important blood-stage P. falciparum
                                                                                 Freely available online PNAS open access option.
proteins, display potential drug blood-
stage vaccine targets.                                                           Abbreviations: Tet, tetracycline; ATc, anhydrotetracycline; TetR, Tet repressor; tTA, Tet-
                                                                                 controlled transactivator; CAT, chloramphenicol acetyltransferase; TATi, transactivator    eukaryotes, gene fulfills critical          Toxoplasma gondii; CAM, calmodulin; GPI, glycosylphosphatidylinositol.
role survival, targeted gene disruption replaced                                                                                  Data deposition: sequence reported paper deposited GenBank
knockdown approach. Use RNA interference (RNAi)                           database (accession  AY860671).
specifically lower level mRNA consequently                     Â¶M.M.   E.K. contributed equally work.
level corresponding protein.                    å‚¨To correspondence sent present address: Department Microbiology
RNAi-based approaches proved unsuccessful Apicom-                         Molecular Medicine, Faculty Medicine, University Geneva, Centre Medicale
plexa possibly parasites lack key                       Universitaire, 1 Rue Michel-Servet, 1211 Geneva 4, Switzerland. E-mail: dominique.soldati-
enzymes involved process (4). widely used                          favre@medecine.unige.ch.
approach studying essential genes tetracycline (Tet)-                  â€    correspondence addressed. E-mail: crabb@wehi.edu.au.
based transcriptional regulation  Recently, succeeded                  Â© 2005 National Academy Sciences USA



2980 â€“2985 å…© PNAS å…© February 22, 2005 å…© vol. 102 å…©  8                                                            www.pnas.orgå…¾cgiå…¾doiå…¾10.1073å…¾pnas.0500112102
TA AGGGGTACACT TGGGCAGGAGATA ATGCA-3â¬˜),                           (5â¬˜-TAAATCTCGAGGATCCTTAAGACCCACTT), yielding double-stranded oligonucleotides NsiI- PacI-    resulting product inserted XhoI site pHH1 (11).
compatible overhanging ends, allowing insertion corre-
sponding sites pTetR-DHFRTS (6). second step,         Parasites Transfection. Stable transformants T. gondii DHFR-TS-selectable marker exchanged HXGPRT             derived described (12). recipient strain p7TetOS1LacZ-
SacII digestion. expression TATi-1 TATi-2 HeLa      p7TetOS1HXGPRT-CAT described (6). ran-
cells, amplified respective genes using primers TATi-6     dom integration screening, 109 recipient parasites trans-
(5â¬˜-CCGGAATTCACCATGTCGCGCCTGGACAAGAGC-                            fected pTRep-DHFRTS selected resistance 3â¬˜) TATi-7 (5â¬˜-CCGGGATCCCGGTGATTAATTA-                        pyrimethamine mycophenolic acidå…¾xanthine ab-
AGCGTTAATATTTTGTTAAAATTCGCG-3â¬˜); used                      sence ATc  ref. 6). TATi-1-, TATi-2-, TATi-3-
PCR fragments generated replace tTA2s         expressing parasites obtained stable integration vector pUHD16-3 using EcoRI BamHI, respectively.       respective expression vector parasites lacking HXGPRT (RH-
stable expression TATi-1 TATi-2 P. falciparum,       hxgprt). Positive clones examined transactivator expres-
amplified gene using primers TATi-4 (5â¬˜-CCGCTC-              sion Western blotting indirect immunofluorescence assay
GAGAATGTCGCGCCTGGACAAGAGC-3â¬˜) TATi-5                          (IFA) (data shown). Blood stages P. falciparum strain D10
(5â¬˜ ACCTAGGTGAT TA TA AGCGT TA ATAT T T T-                   cultivated synchronized described (13, 14). P.
GTTAAAATTCGCG-3â¬˜) inserted resulting PCR                 falciparum ring-stage parasites transiently stably trans-
fragment XhoI AvrII sites vector pHHMI     fected 50â€“100 â?®g purified plasmid DNA (Plasmid Maxi produce pHH-TATi-1 pHH-TATi-2, respectively. CAT           Kit, Qiagen, Valencia, CA) modified electroporation
reporter plasmids generated inserting HindIIIâ€“SphI      conditions (2, 8, 15). HeLa cells (XL1.6) transiently
PCR fragment encoding seven TetO sequences upstream        transfected described (16).
minimal calmodulin (CAM) promoters constructs
pCAM5.4å…¾3, pCAM5.5å…¾3, pCAM5.6å…¾3 (8), resulting             Results
plasmids pTOCAM5.4å…¾3, pTOCAM5.5å…¾3, pTOCAM5.6å…¾3.




                                                                                                                                         MICROBIOLOGY
                                                                  Isolation Characterization Functional Transactivators T.
   create constructs generation parasites stably    gondii. Recently, described insertion mutagenesis ap-
expressing TATi-1 TATi-2 regulatable CAT reporter      proach identifying functional transactivating domains T.
gene, PCR fragments encoding seven TetO minimal CAM           gondii integrating random linear DNA fragment encoding
promoters pTOCAM5.4å…¾3 pTOCAM5.6å…¾3 inserted             resistance marker gene TetR stop codon NotI sites pHH-TATi-1 pHH-TATi-2. primers      genome recipient strain T. gondii (6). strain
used Tet-s (5â¬˜-AAGCGGCCGCTTTCGATACCGTC-                      includes reporter gene (LacZ) selectable marker gene
GACCTCGAGTTTAC-3â¬˜) CAM (5â¬˜-AAGCGGCCG-                      (HXGPRT) control TetO-minimal promoter
CATCGATA ACTGCAGCTGGCGATCCTGATATAT T-                             (p7TetOS1). genetic screen led isolation TCTATTAGG-3â¬˜). KpnI-digested DNA fragments pTO-              functional TetR transactivator, termed TATi-1 (6). Using CAM5.4å…¾3 pTOCAM5.6å…¾3 encoding respective mini-            strategy  isolated second transactivator, termed
mal CAM promoters CAT reporter introduced           TATi-2. Surprisingly, sequence TATi-2 matched pTO5.6å…¾TATi-2. generated plasmids pTC5.4å…¾TATi-1,         perfectly TATi-1, indicating insertion pTC5.6å…¾TATi-1, pTC5.4å…¾TATi-2, pTC5.6å…¾TATi-2.                  occurred locus. analysis DNA
   construct pTGPI-GFP, 5â¬˜ 3â¬˜ ends EGFP        sequence showed integration random 
flanked sequence encoding signal peptide     T. gondii genome anticipated glycosylphosphatidylinositol (GPI)-anchor signal P. falcipa-   occurred plasmid backbone previously inte-
rum MSP-1, respectively, using MSP-1ss (5â¬˜-AGGATCGCT-          grated plasmids (data shown).  sequence GCAGGTCAAAATGAAGATCATATTCTTTTTATGT-3â¬˜                             TATi-2 different TATi-1; difference 5â¬˜-GT TCT TCTCCT T TACTCAT T TCATGTGT TAC-                    integration different positions, resulting shorter TetR
ACATTGTGTA-3â¬˜), EGFP (5â¬˜-TACACAATGTGTAACAC-                       fusion protein (Fig. 1A). Note TATi-1 TATi-2, ATGAAATGAGTAAAGGAGAAGAAC-3â¬˜ 5â¬˜-TCCG-                          short C-terminal deletions observed TetR predicted GAAGAACTACAGAATACAATTGCTTTTAAATC ACT-                             influence DNA binding induction Tet (17).  TATi-1
3â¬˜), MSP-1gs (5â¬˜-AGTGATTTAAAAGCAATTGTAT-                      TATi-2 considered artificial  endogenous) T.
TCTGTAGT TCT TCCGGA-3â¬˜ 5â¬˜-TGA AGA AACT-                       gondii transactivators.
AGTTTAAAATAAATTAAATAC-3â¬˜) primers PCRs.                       primary sequences TATi-1 TATi-2 differ,
products sewn subsequent rounds PCR      amino acid composition transactivating domains produce GPIâ€“GFP fragment. PCR fragment comprising          similar, having predominance hydrophobic CAM 3â¬˜ UTR (8) amplified using primers             polar residues (Fig. 1B). screen artificial transactivating
5â¬˜-GCAGAACTGCAGCGTATTATATTACTAGTTTTTA-                            domains yeast retrieved transactivator (referred AATATGCAGA-3â¬˜ 5â¬˜-GATTCGATCGATCACTTA-                          TATi-3) minimal transactivating domain ATAAAAAAGAGGA-3â¬˜, digested PstI ClaI,                amino acids (18). TATi-1 TATi-2, sequences ligated downstream CAM minimal promoter             transactivating domains relatively hydrophobic intermediate vector pTO5.6å…¾TATi-2  . new           polar. hand, minimal transactivating domain
plasmid digested PstI SpeI GPIâ€“GFP      present tTA, functional T. gondii, highly
fragment ligated CAM minimal promoter         acidic contains polar amino acids (Fig. 1B).
3â¬˜ UTR. HSP86 promoter driving TATi-2 expression             compare strength artificial transactivating
excised replaced MSP-2 promoter (9) BglII    domains, TATi-1, TATi-2, TATi-3 stably expressed XhoI sites. Finally, BglII fragment comprising Rep-20       T. gondii tachyzoites tested ability transactivate
repeat sequence (3) inserted BglII site    minimal Tet-responsive promoter (6). expected, original
MSP-2 CAM promoters controlling expression human       tTA (7) did transactivate TetO-minimal promoter T.
dihydrofolate reductase (hDHFR). generate pHHå…¾TetR,        gondii, TATi-1 TATi-2 demonstrated strong trans-
complete TetR sequence amplified PCR pHD360           activating capacity parasite (Fig. 1C). ATc reversed (10) using oligonucleotides TetR (5â¬˜-CGAAGCTC-         transactivation TATi-1 TATi-2;  
GAGTATGTCAAGATTAGATAAAAGTA) TetR.Rev                          ground activity substantially higher case TATi-2

Meissner et al.                                                                     PNAS å…© February 22, 2005 å…© vol. 102 å…©  8 å…© 2981
                                                                                   Fig. 2. Functional expression TATi-1 TATi-2 P. falciparum analyzed
                                                                                   transient transfection.   Schematic diagram expression vectors
                                                                                   used generate drug-resistant P. falciparum (D10 line) transfectants express-
                                                                                   ing TATi-1 TATi-2. (B) Western blot analysis parasites expressing
                                                                                   TATi-1 TATi-2  control, TetR protein. (C) Quantification CAT
                                                                                   activity parasites transiently transfected reporter constructs contain-
                                                                                   ing minimal CAM promoters different lengths flanked upstream seven
                                                                                   TetO sequences length CAM promoter (pCAM5å…¾3; ref. 8). Black
Fig. 1. Functional transactivators T. gondii.   alignment           boxes represent previously defined promoter elements (8). D10-TATi-2 para-
transactivating domains (boxed) compared C terminus TetR.          sites incubated 48 h presence absence ATc transient
italicized residues arose introduced restriction site. (B) Amino acid      transfection reporter plasmids. Data independent exper-
composition transactivating domains. percentages acidic  , basic      iments. (D) Measurement promoter activity presence different ATc
(KR), charged (RKHYCDE), polar (NCQSTY), hydrophobic (AILFWY) amino            concentrations analyzed transient conditions  instance
acids transactivation domains tTA, TATi-1, TATi-2, TATi-3       pCAM5.1å…¾3 plasmid used positive control (8).
determined using PROTEAN program (DNASTAR, Madison, WI). (C) T.
gondii transactivators different efficiencies. T. gondii parasites express-
ing tTA, TATi-1, TATi-2, TATi-3 transiently transfected           T. gondii genetic screen capable interacting factors
reporter plasmid T7S1LacZ-CAT incubated presence absence          conserved higher eukaryotic transcription machinery, TATi-1
ATc â¬‡48 h. summary independent experiments shown. (D) T.         TATi-2 tested ability transactivate gondii transactivators functional HeLa cells. HeLa line XL1å…¾6,      Tet-responsive minimal promoter, PhCMV*-1 (7) HeLa cells. contains gene luciferase control target pro-
                                                                                   transient transfection conditions, stimulation pro-
moter PhCMV* (7), transiently transfected expression plasmids tTA,
TATi-1, TATi-2. Cells grown 24 h presence absence                                                                                    moter activity detectable TATi-1 TATi-2,
doxycycline (Dox) luciferase LacZ  internal standard) expres-     tTA allowed gene regulation â¬Ž5 orders sion determined. summary independent experiments shown.          magnitude (Fig. 1D). result suggests TATi-1                                                                                    TATi-2 interact transcription factors present                                                                                    higher eukaryotes. Similarly, transactivating domain (Fig. 1C). Unexpectedly, TATi-3 allowed activa-                      TATi-3, originally identified yeast, active tion reporter gene presence ATc,                     mammalian cells (18).
background activity detected absence ATc (Fig.
1C). significant difference amino acid composition                   TATi-1 TATi-2 Act Functional Transactivators P. falciparum.
TATi-3 high portion charged amino acids (Fig. 1B).                    determine T. gondii transactivators functioned speculate unique characteristics TATi-3                  P. falciparum, generated constructs TATi-1 transactivating domain modify TetR binding properties, render-                     TATi-2 placed control P. falciparum HSP86
ing activator reversed DNA-binding activity.                       promoter (Fig. 2A). selection episomal maintenance Similar transactivators identified previously (19).                      plasmid obtained transgenic parasite lines expressing
   determine activating domains identified                   TATi-1 TATi-2 (Fig. 2B). strong expression 
2982 å…© www.pnas.orgå…¾cgiå…¾doiå…¾10.1073å…¾pnas.0500112102                                                                                                 Meissner et al.
                                                                                                                                                                       MICROBIOLOGY
Fig. 3. Transactivation regulation promoter activity stably transfected P. falciparum.   Stable induction CAT control inducible
minimal promoters. Parasites stably transfected plasmid constructs designed express TATi transactivators CAT control particular
regulatable CAM minimal promoters assayed CAT activity. elements controlling transcription TATi proteins hDHFR plasmids Fig. 2  Results expressed relative CAT activity previously described CAT-expressing line, D10-HC1å…¾CAT (20), analyzed parallel.
(B) Regulation stable transgenic P. falciparum lines ATc. day 0, identical cultures split groups, termed â€˜â€˜sample â€™ â€˜â€˜sample B.â€™â€™
Sample cultures maintained absence ATc 4 days  growth cycles), sample B parasites grown presence 0.5 â?®gå…¾ml
ATc period. Results expressed percentage ratio CAT activity sample B sample  (C) D10-HC1å…¾CAT D10-TC5.6å…¾TATi-2 parasites subjected ATc regulation described  sample B maintained presence ATc day 6, time ATc removed. data point mean (â«¾SD) values linear range independent experiments.


 transactivators surprising                            promoter constructs activated degree achieved similar stable expression P. falciparum TetR (Fig.                   TATi-2 transient conditions.
2B) number TetR mutants using similar approaches
(data shown).  despite extreme bias P.                       Establishment ATc-Regulated-Expression P. falcipa-
falciparum, codons transactivators opti-                      rum. Tet derivatives toxic P.
mized P. falciparum, optimization proven                   falciparum, used ATc regulate TATi-induced transactiva- necessary strong expression GC-rich transgenes                      tion. evidenced study  , ATc organism (20â€“22).                                                              toxic P. falciparum levels 0.5â€“1.0 â?®gå…¾ml,    monitor promoter activation TATi-1 TATi-2,                           longer-term continuous culture (â¬‡1 month). transient
generated ATc-responsive promoters based previously                           conditions, CAT expression parasites transfected scribed CAM-minimal promoters fused seven TetO sequences                         control construct encoding CAT transcriptional control (Fig. 2C). CAT activity monitored 48 h transient                          length CAM promoter (pCAM5å…¾3) affected transfection constructs parental parasites par-                    presence ATc. contrast, ATc-responsive minimal
asites expressing TATi-1 TATi-2. preliminary experi-                        promoter plasmids showed clear difference CAT activity
ment, observed  transfection wild-type                         noninduced induced states (Fig. 2C). control parasites yielded little expression minimal                        established ATc concentrations low 0.1 â?®gå…¾ml
promoters, substantial activation CAT expression                    achieved similar levels regulation (Fig. 2D).
parasites expressing TATi-2 small degree activation                        test efficiency transactivation parasites stably
parasites expressing TATi-1 (data shown). noticed                       transfected ATc-responsive promoters, generated
expression TATi-1 diminished persistent mainte-                        constructs containing expression cassette TATi-1 nance parasites selection (data shown).                      TATi-2 CAT reporter gene control discrepancy activation TATi-1 TATi-2                         ATc-responsive promoters pTOCAM5.4å…¾3 explained reduced expression level TATi-1. view                     pTOCAM5.6å…¾3 (Fig. 3A). Substantial promoter activation loss expression TATi-1, transient transfections                   observed parasites transfected pTC5.6å…¾TATi-2, reaching TATi-2-expressing parasites repeated, cumu-                       30  CAT activity compared parasites trans-
lative results presented Fig. 2C. minimal                          fected positive control plasmid pHC1å…¾CAT (20). Rel-

Meissner et al.                                                                                          PNAS å…© February 22, 2005 å…© vol. 102 å…©  8 å…© 2983
atively weaker promoter activation seen combi-
nations transactivator minimal promoter (Fig. 3A). high degree variation different reporter constructs explained different levels TATi-1 TATi-2
expression different lines (data shown).
   compared CAT activities growth parasite
cycles presence absence ATc parasite lines
D10-TC5.4å…¾TATi-1, D10-TC5.6å…¾TATi-2, D10-HC1å…¾CAT. regulatable parasite lines, significant reduction (10- 20-fold) CAT activity evident presence ATc
relative identical cultures grown parallel absence ATc, difference CAT activity observed positive control parasite D10-HC1å…¾CAT presence absence ATc (Fig. 3B).
   Time course experiments performed using D10-
TC5.6å…¾TATi-2 line, consistently demonstrated best regulation (Fig. 3C). 2 days presence ATc,
CAT activity significantly reduced, reaching baseline activity 4 days incubation. day 6, ATc removed, resulting reactivation regulatable promoter maximal
expression level 6 days incubation. absence ATc effect expression CAT control
D10-HC1å…¾CAT line shows ATc toxic effect P.
falciparum concentration (Fig. 3C).
   better examine regulation validate  inserted GFP control ATc-regulatable
promoter pTOCAM5.6å…¾3. attempt maximize prospects rapid turnover reporter, GFP gene fused sequence encoding N-terminal signal peptide                                                                      Fig. 4. Inducible stage-specific expression GFP fusion protein P.
C-terminal GPI addition sequence. resulting construct            falciparum.   Diagram pTGPI-GFP plasmid containing necessary
allows ATc-regulated expression GFP stage-specific            elements including selectable marker (hDHFR) length CAM
expression TATi-2 control MSP-2 promoter         promoter, transactivator (TATi-2), GPIâ€“GFP cassettes, controlled
(9) (Fig. 4A). observed transgenes         Tet-responsive promoter. TATi-2 control MSP-2
encoding GPI-anchored proteins toxic P. falcipa-       promoter (M5â¬˜; ref. 9) Rep-20 element (3). plasmid stably
rum (R.  Oâ€™Donnell B.S.C., unpublished data), line        transformed D10 parasites continual presence ATc. (B) Assessment maintained presence 0.5 â?®gå…¾ml ATc              ATc regulation. culture transformed parasites maintained duration selection period transfection (3â€“4 weeks).     absence ATc split identical cultures maintained                                                                      absence presence ATc growth cycle. Lanes 1â€“ 6 represent 8-h drug-resistant line established, ATc removed
                                                                     time points synchronized ring-stages analyzed Western blotting medium, resulting presence fluorescent            probing antibodies HSP70, MSP-2, GFP. (C) GFP fluorescence
parasites â¬‡20  population. activated  e.,    schizont-stage parasites. Parallel cultures parasites maintained
ATc) line synchronized separated identical          presence absence ATc isolated uninfected red blood
cultures. ATc added cultures, samples     cells microscopy. Phase, phase contrast.
taken cultures ATc 48-h
period. Using Western blotting fluorescence micro-
scopic analysis, confirmed GFP effectively spe-       function elements stably inte-
cifically regulated addition ATc undetectable       grated genome.  lack success date
levels single parasite cycle (Fig. 4 B C). Using      approach, uncertainty surrounding
limiting-dilution Western blot approach, estimated     potential RNA interference (RNAi) organism, led
â¬Ž50-fold regulation. difference expression level           explore possibility ATc-regulated transactivators
observed endogenous protein MSP-2 heat shock              functional T. gondii function P. falciparum.
protein HSP70 (Fig. 4C). Importantly, timing induced         TATi-1 TATi-2 obtained random insertion-
GFP life cycle similar       based genetic screen T. gondii. eventuated insertion
schizont-stage protein MSP-2, promoter drives       T. gondii line random:  integration transactivator TATi-2 line.                                  preexisting plasmid backbone  different reading frames)
                                                                     favored.  transactivating domains TATi-1 Discussion                                                           TATi-2 correspond parasite proteins instead
Methods modulate gene expression P. falciparum blood           essentially adventitiously derived polypeptides com-
stages required analysis gene function        mon predominantly hydrophobic amino acid composition organism. group, example, focused devel-          absence charged amino acids. presumably general
oping direct TetR-regulated endogenously            characteristics provide transactivating capacity TetR-
expressed TetR intended reversibly inactivate length      fusion protein. contrast, transactivating domain tTA,
parasite promoters binding Tet operators placed close       strong transactivator used Tet-regulated expression proximity transcriptional start sites. Despite achieving strong   higher eukaryotes, highly acidic. HeLa cells, TATi-1
stable expression wild-type mutant TetR             TATi-2 inactive, suggesting fundamental differences different P. falciparum promoters, did observe repression     transcription machinery T. gondii host. different TetO-containing HSP86 MSP-2 pro-          Consistent hypothesis, bioinformatics approach 
moter constructs using transient transfection approach        vealed basic transcription machinery Apicomplexan
(T.F.d.K.-W. B.S.C., unpublished data). possible      parasites contains minimal set general transcription

2984 å…© www.pnas.orgå…¾cgiå…¾doiå…¾10.1073å…¾pnas.0500112102                                                                                   Meissner et al.
factors including TBP, TFB  homologue TFIIB), TFE                             eliminate heterogeneity  fact
 homologue TFIIE-â?£) resembles RNA polymerase                              expression profile GFP perfectly mimics steady- Archaea (M.M. D.S., unpublished observations).                           state level MSP-2 entire erythrocytic cycle suggests
   TATi-1 TATi-2 function ATc-responsive transactiva-                           TATi-2 transcript protein rapidly turned tors range ATc shows toxicity effects                       parasites.  regulation TATi-2 expression blood stages P. falciparum. TATi-2 tolerated                          stage-specific promoter imposes second level control expressed P. falciparum capable regulating CAT                         activity regulatable promoter addition modulation reporter 10- 20-fold GFP reporter factor                           ATc. considerable parasite â¬Ž50-fold stable lines. Using GFP, demonstrated                              expression individual gene carefully induced
inactivation gene expression rapid occurs single                    required.
cycle addition ATc. rapid regulation                                 stands, considerable potential observed CAT growth cycles required                             analysis blood-stage gene function P. falciparum. maximally suppress expression. likely primary                           inability observe transgene expression transiently
reason slower regulation higher background                           using sensitive reporters) long time
presence ATc seen bacterial CAT related                              period initial transfection analysis case stability enzyme. stability CAT result                       stable transformants (usually 1â€“2 months), strong expression carryover preexisting enzyme growth cycle                          transgenes particularly problematic organism, espe-
(resulting slower regulation) accumulation small                      cially transgene impacts negatively growth.
amounts CAT parasites maintained presence ATc                           ATc-regulation described result expected minimal promoter activity                          immediate practical value stage-specific expression trans-
circumstance (resulting higher bac